Table 1.

Patient demographicsa

a ATG, antithymocyte globulin; DR, donor-recipient.
b 88.2% of rejections occurred within 3 mo.
c 9 subjects had a rejection episode between 3 mo and 8.1 yr.
Mean age (± SD)39.0 ± 15.3 yr
Gender
 male114 (65.9%)
 female59 (34.1%)
Patients with rejection within 3 mo67 (38.7%)b
Median time to rejection (range)14 d (1 d to 8.1 yr)c
Median follow-up8.3 yr
Proportion treated with ATG11 (6.4%)
Donor
 cadaveric162 (93.6%)
 live11 (6.4%)
No. of grafts
 1147 (84.9%)
 223 (13.3%)
 32 (1.2%)
 41 (0.6%)
HLA DR mismatch
 066 (38.2%)
 165 (37.6%)
 25 (2.9%)
 unknown37 (21.4)
Presenting pathology
 diabetes7 (4.1%)
 glomerulonephritis56 (32.4%)
 reflux29 (16.8%)
 dysplasia8 (4.6%)
 obstructive uropathy10 (5.8%)
 hereditary causes22 (12.7%)
 unknown etiology41 (23.6%)